Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
04/2003
04/10/2003WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof
04/10/2003WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands
04/10/2003WO2003028727A1 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors
04/10/2003WO2003028726A1 Quinoline derivatives as neuropeptide y antagonists
04/10/2003WO2003000175A3 Pediatric formulation of gatifloxacin
04/10/2003WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
04/10/2003WO2002071827A3 Retinoid x receptor modulators
04/10/2003WO2002060423A3 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
04/10/2003WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
04/10/2003US20030069284 Anticancer agent
04/10/2003US20030069271 Quinolone compounds for use in treating viral infections
04/10/2003US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease
04/10/2003US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses.
04/10/2003CA2462030A1 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors
04/10/2003CA2461686A1 Preparation of an anhydrous quinoline-based cetp inhibitor by crystallization
04/10/2003CA2459868A1 Preparation of hiv protease inhibitors
04/09/2003EP1299360A2 Heterocycle carboxamides as antiviral agents
04/09/2003EP1299359A1 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
04/09/2003EP1299352A2 Compounds to treat alzheimer's disease
04/09/2003EP1299349A2 Compounds to treat alzheimer's disease
04/09/2003EP0928200B1 Therapeutic combinations of rar antagonists and rxr agonists
04/09/2003EP0843663B1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
04/09/2003EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105107C Method of purifying quinaldine
04/08/2003US6545155 Fused heteroaromatic glucokinase activators
04/08/2003US6545018 Oxamic acids and derivatives as thyroid receptor ligands
04/08/2003US6545015 Useful in therapy of bacterial infections, fungal infections
04/08/2003US6545008 Pyrimidine derivatives and processes for the preparation thereof
04/08/2003US6544990 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors
04/08/2003CA2112165C Bicyclic amine derivatives
04/08/2003CA2053216C Saturated hydroxyalkylquinoline acids as leukotriene antagonists
04/04/2003WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/04/2003CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/03/2003WO2003027132A2 METHOD OF PREPARING 17β-(N-TERT-BUTYLCARBAMOYL)-3-ONE STEROID DERIVATIVES
04/03/2003WO2003027073A1 Process for producing optically active 7-{2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl}-3,5-dihydroxyhept-6-enoic acid ester
04/03/2003WO2003026667A1 Quinazolino- and quinolino- guanidines as ligands for the neurop eptide ff (npff) receptors
04/03/2003WO2003026659A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
04/03/2003US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
04/03/2003US20030065010 Preparation of anhydrous cetp inhibitor
04/03/2003US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
04/03/2003US20030064977 Viricides
04/03/2003CA2688860A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/02/2003EP1296967A1 Quinolinyl and benzothiazolyl ppar-gamma modulators
04/02/2003EP1296953A2 Methods and compounds for inhibiting mrp1
04/02/2003EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
04/02/2003EP1296931A2 Polyamine analogues as cytotoxic agents
04/02/2003EP1218345B1 Method of making metal 8-quinolinolato complexes
04/02/2003CN1104422C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
04/02/2003CN1104418C Benzoheterocyclic derivatives
04/02/2003CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541661 Inhibitors of histone deacetylase
04/01/2003US6541645 Electron-driven chirality switches
04/01/2003US6541636 Such as 3-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl) prop-2-enenitrile by reacting 2-cyclopropyl-4-(4-fluorophenyl) quinoline-3-carbaldehyde with acetonitrile in the presence of base, then dehydrating; enzyme inhibitors
04/01/2003US6541500 Fungicide mixture
04/01/2003US6541498 Benzenesulfonamides and the use thereof to modulate the activity of endothelin
04/01/2003US6541481 Substituted bicyclic derivatives useful as anticancer agents
04/01/2003US6541477 Inhibitors of p38-a kinase
04/01/2003US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
04/01/2003US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses.
03/2003
03/31/2003WO2002030425A1 Preventives and remedies for complications of diabetes
03/31/2003CA2424060A1 Preventives and remedies for complications of diabetes
03/27/2003WO2003024955A2 Small molecule inhibitors of caspases
03/27/2003WO2003024946A2 Oxamate derivatives containing a variously substituted nitrogen heterocycle
03/27/2003WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/27/2003WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2003024441A1 Novel use of tricyclic compound
03/27/2003WO2003024395A2 Linked biaryl compounds
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003US20030060631 An amine substituent at the 7-position of the quinolone-carboxylic acid derivative is produced; bactericides
03/27/2003US20030060474 A piperazine compound as antithrombotic agent
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060456 Such as 4-(2,3-dihydro-1-benzothien-5-yloxy)-3-((methylamino) methyl)-benzenesulfonamide for use as serotonin re-uptake inhibitors (SSRIs) in treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1295514A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
03/26/2003EP1294694A2 Process for the preparation of quinoline derivatives
03/26/2003EP1294366A1 Pharmaceutical compounds for treating copd
03/26/2003EP1146873A4 Anti-androgens and methods for treating disease
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation
03/26/2003EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1405155A 5-chloro-8-hydroxyquinoline preparation method
03/25/2003CA2379005A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/20/2003WO2003022810A1 3-amino carbonyl-substituted benzoylcyclohexanediones that can be used as herbicides
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022785A2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
03/20/2003WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055087 As analgesic
03/20/2003US20030055086 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
03/20/2003US20030055077 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
03/20/2003US20030055071 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV